Comparative Pharmacology
Head-to-head clinical analysis: HELIUM USP versus MEDICAL AIR USP.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HELIUM USP versus MEDICAL AIR USP.
HELIUM, USP vs MEDICAL AIR, USP
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Helium is an inert gas that reduces airway resistance and improves laminar flow due to its low density, thereby decreasing work of breathing and facilitating gas exchange. It also enhances diffusion of carbon dioxide and oxygen.
Medical Air, USP is a mixture of gases (primarily oxygen and nitrogen) that provides physiological oxygen for cellular respiration.
Inhaled admixture of 60-80% helium with 20-40% oxygen via face mask or endotracheal tube; titrated to clinical response for upper or lower airway obstruction.
Inhalation route: 1-15 L/min via mask or nasal cannula, titrated to maintain SpO2 ≥90%.
None Documented
None Documented
Helium has no true elimination half-life in the body as it is not metabolized and its elimination is entirely dependent on ventilation. The washout half-life from blood and tissues is approximately 2-4 minutes with normal ventilation, but can be prolonged in hypoventilation or in poorly perfused compartments.
Rapid washout; elimination half-life approximately 5-10 minutes with normal ventilation; clinically negligible accumulation.
Helium is an inert gas. Following administration, it is eliminated unchanged via exhalation (essentially 100% pulmonary excretion). Renal, biliary, or fecal elimination is negligible.
Primarily exhaled unchanged via lungs; minimal non-pulmonary elimination (<5% metabolized or excreted renally as trace CO2 and water).
Category C
Category C
Medical Gas
Medical Gas